What Researchers Did
Researchers examined how hyperbaric oxygen therapy (HBOT) affects DNA damage markers in the blood cells of patients undergoing treatment for diabetic foot ulcers.
What They Found
They observed a statistically significant increase in mean sister chromatid exchange (SCE) per cell (P < 0.05; n = 11) immediately after the first HBOT session. While SCE frequency gradually decreased after the 5th and 10th sessions, returning to baseline, lymphocytes retained a significantly higher sensitivity (P < 0.05; n = 4) to mitomycin C-induced SCE even one day after the last of 10 daily HBOT treatments.
Canadian Relevance
This study covers diabetic foot ulcers, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A key limitation was the decreasing number of patients available for sampling throughout the 10-session therapy protocol.